La 11° International AIDS Society (IAS) Conference on HIV Science si terrà in forma virtuale a partire da domenica prossima: dal 18 al 21 luglio.
Qui il programma, come sempre enorme e dispersivo.
A parte la onnipervasiva presenza di Covid e coinfezioni Covid-HIV, molte le sezioni dedicate alla ricerca di una cura e alla ricerca sui nuovi farmaci. In particolare, domenica 18 si parte con HIV reservoirs: Lessons for cures e con HIV reservoir regulation and cure.
Lunedì 19, segnalo
- HIV vaccines and immunotherapy: Quo vadis?
Old versus New: New ARV Drug Classes Open Up New Therapeutic Choices For The Multiclass Resistant Patients. What Can Be Achieved?
HIV Cure & Gene Therapy Forum opening session
Advances in gene therapy (HIV Cure & Gene Therapy Forum) e
What is coming next for in vivo gene therapy? (HIV Cure & Gene Therapy Forum)
Waving the wand: Untangling HIV reservoir dynamics
Will there be a next generation HIV vaccine if current ones fail?
Martedì 20, tante discussioni sulla cART:
- Antiretroviral therapy: Time to change the paradigm? e
Let's talk about switch: optimizing ART for your patients today,
The time for long-acting is now – taking a new approach in treatment of people living with HIV e
ART today and tomorrow.
Ma non solo cART. Anche anticorpi monoclonali: COVID-19 and HIV: Monoclonal antibodies for their prevention and treatment; vaccini: An HIV vaccine: who needs it?; infiammazione: Inflammation and tissue damage: Causes and repair mechanisms; ancora terapia genica: Advances in in vivo cell and gene therapy (HIV Cure & Gene Therapy Forum) e Bringing curative genetic interventions for HIV and sickle-cell disease to resource-limited settings (HIV Cure & Gene Therapy Forum).
Infine, mercoledì 21: Why are so many people still dying from AIDS? Turning the tide on advanced HIV e In it together: Co-infections in people living with HIV.
Non so se e che cosa riuscirò a scrivere. Vedremo quali materiali saranno resi disponibili dagli organizzatori e quando.